BR100 Decreased By (-0.08%)
BR30 Increased By (0.08%)
KSE100 Decreased By (-0.11%)
KSE30 Decreased By (-0.2%)
AGHA 7.53 Decreased By ▼ -0.10 (-1.31%)
BECO 5.11 Decreased By ▼ -0.46 (-8.26%)
BML 58.30 Decreased By ▼ -1.44 (-2.41%)
BOP 34.58 Increased By ▲ 0.18 (0.52%)
CNERGY 13.68 Increased By ▲ 0.57 (4.35%)
CSIL 6.30 Decreased By ▼ -0.11 (-1.72%)
FCCL 57.55 Decreased By ▼ -0.51 (-0.88%)
FFL 16.50 Increased By ▲ 0.27 (1.66%)
FNEL 1.20 Decreased By ▼ -0.01 (-0.83%)
KEL 7.36 Decreased By ▼ -0.07 (-0.94%)
KOSM 5.98 Decreased By ▼ -0.05 (-0.83%)
LOTCHEM 27.51 Decreased By ▼ -0.16 (-0.58%)
MLCF 101.93 Decreased By ▼ -0.82 (-0.8%)
NBP 203.29 Decreased By ▼ -1.77 (-0.86%)
NCPL 60.47 Increased By ▲ 0.84 (1.41%)
NPL 69.80 Increased By ▲ 1.24 (1.81%)
OGDC 318.48 Decreased By ▼ -0.44 (-0.14%)
PACE 11.12 Increased By ▲ 0.07 (0.63%)
PAEL 42.86 Decreased By ▼ -0.24 (-0.56%)
PIBTL 16.72 Increased By ▲ 0.09 (0.54%)
PPL 230.62 Increased By ▲ 1.17 (0.51%)
PRL 76.73 Increased By ▲ 5.93 (8.38%)
PTC 71.18 Increased By ▲ 0.18 (0.25%)
SSGC 27.10 Decreased By ▼ -0.31 (-1.13%)
TBL 10.28 Decreased By ▼ -0.03 (-0.29%)
TELE 8.56 Increased By ▲ 0.03 (0.35%)
TPL 23.59 Increased By ▲ 0.53 (2.3%)
TPLP 15.45 Decreased By ▼ -0.31 (-1.97%)
TREET 24.51 Decreased By ▼ -0.20 (-0.81%)
TRG 60.09 Decreased By ▼ -0.20 (-0.33%)

Obesity will soon outscore smoking as the principal risk factor in Germany for cancer, the head of the country's main cancer-research laboratory said on December 29. The reason was the growth in Germany's obesity rate. Overweight people are at greater risk of oesophageal, bowel, kidney, pancreatic and breast cancer, although the precise mechanisms involved have still not yet been fully explained.
"That's an important topic in the next stage of our research," said Otmar Wiestler, head of the German Cancer Research Centre, or DKFZ, told the German Press Agency dpa in Heidelberg.
He said the overall number of cancer cases was bound to rise as the average person's life expectancy grew in Germany.
"Cancers are diseases that mainly show up in old age," he explained.
Professor Wiestler said that of 450,000 people who come down with cancer in Germany every year, about half could expect to be cured and many others could expect therapy that kept the cancer in check.
New drugs and the trend to carefully tailor therapies to the individual promised to increase the rate of cures, he said.
DKFZ in Heidelberg says it is the largest biomedical research institute in Germany with more than 2,200 staff.
"Cure rates will improve," he forecast, adding that scientists "now have a fairly good for the majority of cancers" which genetic mutations and which cellular changes are involved.
"That makes it possible to devise drugs that block such changes. There are more and more drugs that can be prescribed individually, depending on the characteristics of the patient," he said. Single forms of cancer can be of many types, needing different drugs.

Copyright Deutsche Presse-Agentur, 2011

Comments

Comments are closed for this article.